Literature DB >> 28104656

Draft Genome Sequences of Pandrug-Resistant Serratia marcescens Clinical Isolates Harboring blaNDM-1.

Yancheng Yao1, Linda Falgenhauer1, Volkhard A J Kempf2, Michael Hogardt2, Stephan Göttig2, Can Imirzalioglu1, Trinad Chakraborty3.   

Abstract

The draft genome sequences of two clonal, pandrug-resistant Serratia marcescens clinical isolates were determined. The resistance phenotype was plasmid driven, as 14 of 17 resistance genes were present on large IncFIB(K), IncHI2, and IncA/C2 plasmids indicating a large pool of transmissible antibiotic resistance genes.
Copyright © 2017 Yao et al.

Entities:  

Year:  2017        PMID: 28104656      PMCID: PMC5255929          DOI: 10.1128/genomeA.01481-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Serratia marcescens is an environmental organism and colonizer of the gastrointestinal tract of healthy individuals. However, now it is increasingly being recognized as an emerging pathogen, causing severe infections and outbreaks particularly affecting preterms and neonates (1–3). S. marcescens displays intrinsic resistance to ampicillin and colistin, however, clinical isolates of S. marcescens with pandrug resistance are rare (3, 4). The pandrug-resistant S. marcescens isolates SM1978 and SM1890 harboring bla obtained from a leukemia patient and a patient with a urinary tract infection, respectively, were previously described (5). We performed whole-genome sequencing and searched for the location of antibiotic resistance genes in these isolates. Genomic DNA sequencing libraries were prepared using the Nextera XT kit (Illumina, Eindhoven, NL). Sequencing was performed using Nextseq Mid-output reagent kit v2 (2 × 150 bp) on an Illumina NextSeq 500. For SM1890, a total of 6,655,202 reads with an average length of 134 bp were assembled into 174 contigs, giving a total length of 5,865,102 bp and a coverage of roughly 118× (CLC Genomics Workbench 9.0). Plasmid replicons and antibiotic resistance genes were predicted using the CGE platform (https://cge.cbs.dtu.dk/services/) (6, 7). Chromosomal contigs were ordered to the best matched reference strain WW4 (8) using MAUVE (9) and annotated with RAST (http://Rast.nmpdr.org) (10). The gapped draft chromosome of SM1890 comprised 5,358,595 bp with a G+C content of 59.1% and 132 contigs. In addition, contigs had homology to an IncA/C2 plasmid pNDM-KN (JN157804), IncHI2 plasmid p34977-263.138 kb (CP012170), and R478 (BX664015) as well as IncFIB(K) plasmid pKPN3 (CP000648). Three small closed plasmids designated pSM1890ColRNA1 (4,938 bp), pSM1890ColRNA1 (3,223 bp), and pSM1890untypable (2,697 bp), respectively. The average sequencing depth was 70 for the chromosome, 120 for the three large plasmids, and from 11,000 to 13,000 for the three small plasmids. Analysis revealed bla, bla, bla, sul1, sul2, rmtC, aacA4, aac(6′)Ib-c, strA, strB, dfrA18, qnrA1, catA2, aac(6′)-Ic, tet (41), and ampC genes in addition to the bla gene. The majority of the antibiotic resistance genes are located on the IncA/C2, IncHI2A and IncFIB(K) plasmids, with only three (aac[6′]-Ic, tet[41], and ampC) present on the chromosome. The plasmid pSM1890IncA/C2 harbored the transmissible resistance genes bla, bla, sul1, rmtC, aacA4, and aac(6′)Ib-c (5). The IncHI2A and IncFIB plasmids also carried the operons terABCDW, copBCD, arsCBRH conferring resistance toward the heavy metals tellurium, copper, and arsenic. A notable finding was the presence of a gene with homology to methyl-accepting chemotaxis protein (MCP) on the 4,938 bp-ColRNA1 plasmid. The same gene present on plasmid pCSA2 of Cronobacter sakazakii ATCC29544 was previously shown to be involved in adhesion, invasion, and the regulation of mobility and biofilm formation in that isolate (11). For SM1978 a total of 2,036,182 reads with an average length of 130 bp and assembled to a gapped genome length of 5,846,245 bp with ~44× coverage. The genome sequences of both isolates exhibited 99.99% ANI (average nucleotide identity). The exceptional antibiotic resistance profile of these isolates can be attributed to an accumulation of multiple plasmids harboring a wide range of resistance determinants. As these plasmids can be horizontally transferred, these isolates constitute a reservoir for the spread of multidrug-resistance.

Accession number(s).

Raw data and the assembled sequences have been deposited in the European Nucleotide Archive (ENA) under the accession no. FNXV00000000 for SM1890 and FNXW00000000 for SM1978. The versions described in this paper are the first versions, FNXV01000000 and FNXW01000000.
  11 in total

1.  Plasmid-encoded MCP is involved in virulence, motility, and biofilm formation of Cronobacter sakazakii ATCC 29544.

Authors:  Younho Choi; Seongok Kim; Hyelyeon Hwang; Kwang-Pyo Kim; Dong-Hyun Kang; Sangryeol Ryu
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

2.  Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1.

Authors:  Teresa M Gruber; Stephan Göttig; Laura Mark; Sara Christ; Volkhard A J Kempf; Thomas A Wichelhaus; Axel Hamprecht
Journal:  J Antimicrob Chemother       Date:  2014-12-02       Impact factor: 5.790

3.  Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit.

Authors:  Felix Fleisch; Urs Zimmermann-Baer; Reinhard Zbinden; Gian Bischoff; Romaine Arlettaz; Katharina Waldvogel; David Nadal; Christian Ruef
Journal:  Clin Infect Dis       Date:  2002-02-05       Impact factor: 9.079

4.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

5.  progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement.

Authors:  Aaron E Darling; Bob Mau; Nicole T Perna
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

6.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

7.  Complete Genome Sequence of Serratia marcescens WW4.

Authors:  Wan-Chia Chung; Ling-Ling Chen; Wen-Sui Lo; Pei-An Kuo; Jenn Tu; Chih-Horng Kuo
Journal:  Genome Announc       Date:  2013-04-04

8.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

9.  Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen.

Authors:  Atsushi Iguchi; Yutaka Nagaya; Elizabeth Pradel; Tadasuke Ooka; Yoshitoshi Ogura; Keisuke Katsura; Ken Kurokawa; Kenshiro Oshima; Masahira Hattori; Julian Parkhill; Mohamed Sebaihia; Sarah J Coulthurst; Naomasa Gotoh; Nicholas R Thomson; Jonathan J Ewbank; Tetsuya Hayashi
Journal:  Genome Biol Evol       Date:  2014-08       Impact factor: 3.416

10.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043

View more
  1 in total

1.  A High-throughput, High-content, Liquid-based C. elegans Pathosystem.

Authors:  Quinton L Anderson; Alexey V Revtovich; Natalia V Kirienko
Journal:  J Vis Exp       Date:  2018-07-01       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.